CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Clozaril

clozapine· ingredient clozapine· CLOZAPINE 100 mg/1; CLOZAPINE 25 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$11.69
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 8 weeks.

2025-06-012026-06-01

Same-ingredient options by acquisition cost

Other clozapine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
clozapine$0.63307−$11.06
clozapine$4.80−$6.89

Medicare Part D coverage · CY2026

On 1 plan formularies · typical tier 1
Prior auth 100% · Step therapy 0% · Quantity limit 100% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.